scorecardresearch
Add as a preferred source on Google
Wednesday, December 3, 2025
TopicPfizer

Topic: Pfizer

Why the above-90% effective Moderna and Pfizer vaccines are truly a breakthrough

The most important challenge for development of an mRNA vaccine remains its inherent instability.

Pfizer Covid vaccine faces hurdles after USFDA filing

Shown to be 95% effective and without any major safety issues, their vaccine could be the first to be cleared for use, but first it must undergo a thorough vetting.

There’s light at the end of the Covid tunnel — the glimmer of a vaccine needle

With Pfizer, Moderna as well as developers of Sputnik V and CoronaVac citing over 90% efficacy of their vaccines, the world finally has a reason to hope 2021 will be different.

Tracking side effects will be the next big challenge for Pfizer, Moderna Covid vaccines

The side-effect reports of the vaccine have the potential to be a gold mine for anti-vaxxers as vaccine skepticism grows around the world.

Pfizer Covid vaccine reaches key safety milestone, to seek emergency US FDA approval

Pfizer CEO Albert Bourla says important questions about the vaccine still remain to be answered, including how durable the protection could be.

Moderna’s Covid vaccine offers antidote to Pfizer’s deep-freeze problem

While Pfizer's vaccine has to be kept in -70 degree and can only last up to 5 days, Moderna's vaccine can last up to 30 days in regular freezers.

Modi govt eyes pvt sector vaccinators for Covid as India has only 70,000 in public sector

These vaccinators run Universal Immunisation Programme that inoculates mothers & children, and govt is concerned about diverting resources for Covid vaccine.

India’s mRNA-based Covid vaccine won’t need ultra cold conditions for storage — Pune firm

Gennova Biopharmaceuticals CEO Sanjay Singh tells ThePrint their vaccine could be stored at around 2 to 8 degrees Celsius, and the trial is likely to be completed by March.

Pfizer vaccine success opens hot stock-market trade

Given the bets the market has seen in the different pandemic phases — from ventilator makers to medical gloves suppliers — it’s no surprise this new phase is attracting attention.

Temperature challenge can make Pfizer Covid vaccine a shot for the rich

The investment and coordination required to build deep-freeze production, storage & transportation networks for the vaccine will ensure that only rich nations are guaranteed access.

On Camera

Indian bureaucracy doesn’t need DOGE. Hiring more would be better for efficiency

The view that bureaucracies are bloated with far too many employees preying on taxpayers money is a widely held myth. Research shows how significantly understaffed the Indian state is.

India’s Insolvency & Bankruptcy Code is struggling to deliver. It’ll take a decade to clear backlog

The Centre is considering an increase in the National Company Law Tribunal's bench capacity, while the Standing Committee of Finance suggests fast-track courts. 

India to commission new squadron of submarine-hunting Romeo choppers in Goa later this month

The helicopters produced by Lockheed Martin are known as ‘submarine hunters’. India ordered 24 of these aircraft in 2020 to replace the Sea King helicopters. 15 have been delivered till date.

Gaali cricket: Bavuma stands tall, India’s Test ego cut to size

The India-South Africa series-defining fact is the catastrophic decline of Indian red ball cricket where a visiting team can mock us with the 'grovel' word.